News from convergence pharmaceuticals ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

30 Jul, 2013, 08:00 BST Convergence Pharmaceuticals Receives Orphan-Drug Designation for Nav1.7 Blocking Pain Drug CNV1014802

Designation granted by US FDA for the treatment of trigeminal neuralgia Convergence Pharmaceuticals Limited ("Convergence" or "the company"), the...


27 Mar, 2013, 17:24 GMT Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study

Novel sodium channel blocker with excellent pharmacokinetic and safety profile could fill treatment gap for severe pain condition Convergence...


18 Jul, 2012, 09:00 BST Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain

Phase I study data indicates CNV2197944's optimal profile for a chronic pain medication Convergence Pharmaceuticals Limited ("Convergence"), the...


19 Mar, 2012, 09:00 GMT Convergence Pharmaceuticals Announces Start of Phase II Study for CNV1014802 for Trigeminal Neuralgia

Novel sodium channel blocker with excellent pharmacokinetic and safety profile could fill treatment gap for severe pain condition Convergence...


21 Nov, 2011, 09:00 GMT Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944

Phase I Single Dose Study Data Demonstrate Ideal Pharmacokinetic Profile and Excellent Safety and Tolerability Convergence Pharmaceuticals Limited...